Published in Phytochemistry on May 07, 2012
Carbamidocyclophanes F and G with Anti-Mycobacterium tuberculosis Activity from the Cultured Freshwater Cyanobacterium Nostoc sp. Tetrahedron Lett (2014) 0.85
Discovery of Anticancer Agents of Diverse Natural Origin. Anticancer Res (2016) 0.83
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer. Mar Drugs (2015) 0.82
Effects of Halide Ions on the Carbamidocyclophane Biosynthesis in Nostoc sp. CAVN2. Mar Drugs (2016) 0.77
Total synthesis of the putative structure of the proposed Banyasin A. Front Chem (2015) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
PCR primers to amplify 16S rRNA genes from cyanobacteria. Appl Environ Microbiol (1997) 6.70
Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry (2007) 4.27
Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatum. J Nat Prod (2001) 1.97
Biological activities of cyanobacteria: evaluation of extracts and pure compounds. Planta Med (1995) 1.66
Biogenetic diversity of cyanobacterial metabolites. Adv Appl Microbiol (2007) 1.61
Phylogenetic and morphological evaluation of the genera Anabaena, Aphanizomenon, Trichormus and Nostoc (Nostocales, Cyanobacteria). Int J Syst Evol Microbiol (2005) 1.42
The unique mechanistic transformations involved in the biosynthesis of modular natural products from marine cyanobacteria. Nat Prod Rep (2010) 1.19
Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp. J Nat Prod (2007) 1.09
Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp. J Nat Prod (2010) 1.07
Production of secondary metabolites by freshwater cyanobacteria. Chem Pharm Bull (Tokyo) (2004) 1.00
Syntheses of naturally occurring cytotoxic [7.7]paracyclophanes, (-)-cylindrocyclophane A and its enantiomer, and implications for biological activity. Org Biomol Chem (2009) 0.94
Nostocyclyne A, a novel antimicrobial cyclophane from the cyanobacterium Nostoc sp. J Nat Prod (2000) 0.90
Drug discovery from medicinal plants. Life Sci (2005) 4.26
Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry (2005) 3.57
Drug discovery from natural sources. AAPS J (2006) 2.76
Novel synthesis of 1-aroyl-3-aryl-4-substituted imidazole-2-thiones. Org Lett (2003) 2.30
Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A (2006) 2.28
Discovery of anticancer agents of diverse natural origin. Pure Appl Chem (2009) 2.00
FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Mol Cell (2008) 1.99
MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology (2012) 1.96
Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics (2009) 1.84
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood (2009) 1.83
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge. J Nat Prod (2003) 1.81
Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships. J Nat Prod (2011) 1.81
Synthesis, reactivity, and structural characterization of sodium and ytterbium complexes containing new imidazolidine-bridged bis(phenolato) ligands. Inorg Chem (2007) 1.76
Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anticancer Agents Med Chem (2006) 1.76
New chemical constituents of Euphorbia quinquecostata and absolute configuration assignment by a convenient Mosher ester procedure carried out in NMR tubes. J Nat Prod (2002) 1.74
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem (2004) 1.69
Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription. J Biol Chem (2008) 1.66
Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem (2006) 1.54
Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites. Mol Nutr Food Res (2012) 1.48
Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes. J Nat Prod (2009) 1.48
Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab (2008) 1.41
Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod (2002) 1.39
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. J Nat Prod (2009) 1.36
Addition of amines to nitriles catalyzed by ytterbium amides: an efficient one-step synthesis of monosubstituted N-arylamidines. Org Lett (2008) 1.35
The relevance of higher plants in lead compound discovery programs. J Nat Prod (2011) 1.34
Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A (2006) 1.27
Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res (2006) 1.26
Isolation, structure elucidation, and absolute configuration of 26-deoxyactein from Cimicifuga racemosa and clarification of nomenclature associated with 27-deoxyactein. J Nat Prod (2002) 1.26
Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J (2010) 1.26
A highly cross-linked polymeric binder for high-performance silicon negative electrodes in lithium ion batteries. Angew Chem Int Ed Engl (2012) 1.26
Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J Antibiot (Tokyo) (2012) 1.24
Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res (2007) 1.23
Bioactive constituents of the stem bark of Mitrephora glabra. J Nat Prod (2009) 1.23
Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata. J Nat Prod (2010) 1.23
Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling. FEBS Lett (2004) 1.20
Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua. Phytochemistry (2010) 1.17
Cyclodepsipeptides, sesquiterpenoids, and other cytotoxic metabolites from the filamentous fungus Trichothecium sp. (MSX 51320). J Nat Prod (2011) 1.16
Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery. Curr Drug Targets (2011) 1.15
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors. J Med Chem (2005) 1.13
Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. Biochem J (2008) 1.13
Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria. Pharm Biol (2009) 1.12
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum. J Nat Prod (2008) 1.12
Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents. ACS Med Chem Lett (2012) 1.11
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells. AAPS J (2011) 1.11
Structural basis for thermostability revealed through the identification and characterization of a highly thermostable phosphotriesterase-like lactonase from Geobacillus stearothermophilus. Arch Biochem Biophys (2009) 1.10
Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism. Nutr Cancer (2009) 1.10
Activity-guided isolation of cytotoxic constituents from the bark of Aglaia crassinervia collected in Indonesia. Bioorg Med Chem (2005) 1.09
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. J Nat Prod (2009) 1.09
Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal Chem (2008) 1.08
Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem (2007) 1.08
Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp. J Nat Prod (2010) 1.07
Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and anthelmintic activities. J Pept Sci (2012) 1.06
Rapid activation of CLOCK by Ca2+-dependent protein kinase C mediates resetting of the mammalian circadian clock. EMBO Rep (2007) 1.06
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia. J Nat Prod (2004) 1.06
Cytotoxic (9βH)-pimarane and (9βH)-17-norpimarane diterpenes from the tuber of Icacina trichantha. Chem Biodivers (2014) 1.05
Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Devel (2009) 1.05
Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron (2012) 1.05
Greensporones: resorcylic acid lactones from an aquatic Halenospora sp. J Nat Prod (2014) 1.04
An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni). J Nat Prod (2005) 1.04
Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol. Clin Cancer Res (2012) 1.04
Isolation and characterization of proteins associated with histone H3 tails in vivo. J Biol Chem (2007) 1.04
Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci (2012) 1.03
Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: expression of bone and cartilage related genes. Bone (2009) 1.03
RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells. Oncogene (2004) 1.03
Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Curr Drug Targets (2010) 1.02
Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design. J Mol Biol (2007) 1.01
Essential parameters for structural analysis and dereplication by (1)H NMR spectroscopy. J Nat Prod (2014) 1.01